These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5848057)

  • 1. [Relations between inhibition of cerebral monoamine oxidase in mice and the pyridoxal-5-phosphate-monoamine oxidase inhibitor pharmacological antagonism in the presence of 3,4-dihydroxyphenylalanine].
    Lévy J; Michel-Ber E
    J Physiol (Paris); 1965; 57(4):475-83. PubMed ID: 5848057
    [No Abstract]   [Full Text] [Related]  

  • 2. [Demonstration, by a pharmacological test, of relations between the metabolism of some pyridoxine derivatives and the antidepressive action, in the mouse, of monoamine oxidase inhibitor (IMAO)].
    DENYS A; LEVY J; MICHEL-BER E
    C R Hebd Seances Acad Sci; 1962 Nov; 255():2528-30. PubMed ID: 14027059
    [No Abstract]   [Full Text] [Related]  

  • 3. [Structure-action relations of monoamine oxidase inhibitors].
    Matthies H; Fähse C; Lietz W; Jassmann E
    Acta Biol Med Ger; 1967; 19(3):447-61. PubMed ID: 5591162
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative studies on monoamine oxidase inhibitors].
    Matthies H; Lietz W; Fähse C; Pohle W; Popov N; Grade K
    Acta Biol Med Ger; 1966; 17(5):614-36. PubMed ID: 5991587
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of dihydroxyphenylalanine on the serotonin content of rat brain following pretreatment with monoamine oxidase inhibitors].
    Popov N; Matthies H
    Acta Biol Med Ger; 1966; 17(5):637-43. PubMed ID: 5991588
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relations between the antidepressive effects of octamoxine revealed by 3 pharmacological tests and inhibition of cerebral monoamine oxidase in mice].
    Levy J; Michel-Ber E
    Therapie; 1966; 21(4):929-45. PubMed ID: 5925088
    [No Abstract]   [Full Text] [Related]  

  • 7. [Contribution to the study of the mechanism of antidepressive action of monoamine oxidase inhibitors (MAOI) at the level of the central nervous system in the mouse. II. Influence of some pyridoxine derivatives on the antidepressive action of MAOI].
    DENYS A; LEVY J; MICHEL-BER E
    J Physiol (Paris); 1963; 55():381-404. PubMed ID: 14027058
    [No Abstract]   [Full Text] [Related]  

  • 8. [Delta-aminolevulinic oxidase activity of rat liver homogenates in various experimental conditions].
    Pisani W; Bonzanino A; Coscia GC
    Boll Soc Ital Biol Sper; 1967 Jan; 43(2):65-7. PubMed ID: 6049564
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of the effects of some monoamine oxidase (MAO) inhibitors with 5-hydroxytryptophan (5-HTP) and dihydroxyphenylalanine (DOPA) on spinal synaptic activity.
    Anderson EG; Baker R; Banna N
    Proc West Pharmacol Soc; 1966; 9():40-1. PubMed ID: 5958499
    [No Abstract]   [Full Text] [Related]  

  • 10. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
    Caille D; Bergis OE; Fankhauser C; Gardes A; Adam R; Charieras T; Grosset A; Rovei V; Jarreau FX
    J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings: The effect of psychotropic drugs on the dopa potentiation test in mice.
    Berendsen H; Leonard BE; Rigter H
    Br J Pharmacol; 1974 Nov; 52(3):432P-433P. PubMed ID: 4458854
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical properties and kinetic parameters of monoamine oxydase in human seminal plasma.
    Roberge AG; Moufarege A; Lavoie J; Roberge C; Tremblay RR
    Int J Fertil; 1984; 29(3):180-5. PubMed ID: 6152258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings: Physiological and pharmacological studies on 'caudate spindle'.
    Ishikawa T; Kitano K; Yamamoto M
    Jpn J Pharmacol; 1974; 24(0):s:103. PubMed ID: 4151688
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the potentiation of DOPA effects by monoamine oxidase inhibitors].
    Boissier JR; Simon P
    Psychopharmacologia; 1966; 8(6):428-36. PubMed ID: 5923750
    [No Abstract]   [Full Text] [Related]  

  • 15. [Activity of mouse cerebral monoamine oxidase as a function of the means of administration of a MAO inhibitor].
    Levy J; Michel-Ber E
    Therapie; 1966; 21(3):633-44. PubMed ID: 5942129
    [No Abstract]   [Full Text] [Related]  

  • 16. Characteristics of dihydroxyphenylalanine/5-hydroxytryptophan decarboxylase activity in brain and liver of cat.
    Bouchard S; Bousquet C; Roberge AG
    J Neurochem; 1981 Sep; 37(3):781-7. PubMed ID: 6974228
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacologic effects of 2-phenylcycloalkylamines.
    McGrath WR; Kuhn WL
    Arch Int Pharmacodyn Ther; 1968 Apr; 172(2):405-13. PubMed ID: 5684251
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiamphetamine effects following inhibition of tyrosine hydroxylase.
    Weissman A; Koe BK; Tenen SS
    J Pharmacol Exp Ther; 1966 Mar; 151(3):339-52. PubMed ID: 5938473
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: The "pharmacological bridge": a view from the clinical shores.
    Sack R; Goodwin FK
    Psychopharmacol Bull; 1974 Oct; 10(4):52-3. PubMed ID: 4431876
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of dihydroxyphenylalanine administered with a monoamine oxidase inhibitor on glucose metabolism in rat brain.
    Tyce GM
    Biochem Pharmacol; 1971 Sep; 20(9):2371-84. PubMed ID: 5163149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.